Bone mineral loss induced by anticancer treatment for gynecological malignancies in premenopausal women

Keina Nishio(Osaka Medical and Pharmaceutical University), Masahide Ohmichi(Osaka University of Pharmaceutical Sciences), Satoshi Tunetoh(Osaka Medical and Pharmaceutical University), Yoshito Terai(Osaka Medical and Pharmaceutical University), Tatsuharu Sekijima(Osaka Medical and Pharmaceutical University), Kiyoko Nakamura(Osaka Medical and Pharmaceutical University), Akiko Tanabe(Osaka Medical and Pharmaceutical University), Risa Maruoka(Osaka Medical and Pharmaceutical University), Masaaki Takai(Osaka Medical and Pharmaceutical University)
Endocrine Connections
October 13, 2012
10.1530/ec-12-0043
Cited by 31

Related Papers

Estrogen Induces the Akt-dependent Activation of Endothelial Nitric-oxide Synthase in Vascular Endothelial Cells
|Journal of Biological Chemistry|2001|387
Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
|PubMed|2000|249
Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models
|Journal of Biological Chemistry|2004|212
Estrogen Suppresses Transcription of Lipoprotein Lipase Gene
|Journal of Biological Chemistry|2000|209
Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line
|Journal of Biological Chemistry|1999|174